S14 Current Status of Thyroid Cancer Monitoring

Program: Symposia
Clinical Session
Friday, April 1, 2016: 4:45 PM-6:15 PM
Hall B2 (BCEC)
Chair:
Anna M. Sawka, MD, PhD, University Health Network/University of Toronto, Toronto, Canada

Nothing to Disclose: AMS
4:45 PM
Jonathan S. Lopresti, MD, PhD, Endocrinology, University of Southern California, Los Angeles, CA
Nothing to Disclose: JSL
5:15 PM
Robert C. Smallridge, MD, Endocrinology and Metabolism, Mayo Clinic, Jacksonville, FL
Nothing to Disclose: RCS
5:45 PM
Susan J Mandel, MD, MPH, Perelman School of Medicine, University of Pennsylvania, Ardmore, PA
Nothing to Disclose: SJM
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire